Inventor
HAMMANG JOSEPH P
US34 patents
⚠️ This page may combine multiple inventors who share the name “HAMMANG JOSEPH P”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CYTOTHERAPEUTICS INC
15 patentsUS5858747AJan 12, 1999
Control of cell growth in a bioartificial organ with extracellular matrix coated microcarriers
CYTOTHERAPEUTICS INC197 citations99
US5795790AAug 18, 1998
Method for controlling proliferation and differentiation of cells encapsulated within bioartificial organs
CYTOTHERAPEUTICS INC126 citations99
US5776747AJul 7, 1998
Method for controlling the distribution of cells within a bioartificial organ using polycthylene oxide-poly (dimethylsiloxane) copolymer
CYTOTHERAPEUTICS INC129 citations99
US5935849AAug 10, 1999
Methods and compositions of growth control for cells encapsulated within bioartificial organs
CYTOTHERAPEUTICS INC102 citations98
US5653975AAug 5, 1997
Compositions and methods for the delivery of biologically active molecules using cells contained in biocompatible capsules
CYTOTHERAPEUTICS INC153 citations98
US5639275AJun 17, 1997
Delivery of biologically active molecules using cells contained in biocompatible immunoisolatory capsules
CYTOTHERAPEUTICS INC256 citations98
US5676943AOct 14, 1997
Compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules
CYTOTHERAPEUTICS INC95 citations97
US5550050AAug 27, 1996
Method for implanting encapsulated cells in a host
CYTOTHERAPEUTICS INC164 citations97
US5904144AMay 18, 1999
Method for treating ophthalmic diseases
CYTOTHERAPEUTICS INC188 citations96
US5853717ADec 29, 1998
Methods and compositions of growth control for cells encapsulated within bioartificial organs
CYTOTHERAPEUTICS INC67 citations96
US5840576ANov 24, 1998
Methods and compositions of growth control for cells encapsulated within bioartificial organs
CYTOTHERAPEUTICS INC59 citations96
US5833979ANov 10, 1998
Methods and compositions of growth control for cells encapsulated within bioartificial organs
CYTOTHERAPEUTICS INC61 citations96
US6027721AFeb 22, 2000
Device and method for encapsulated gene therapy
CYTOTHERAPEUTICS INC46 citations93
US5908623AJun 1, 1999
Compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules
CYTOTHERAPEUTICS INC37 citations92
US5843431ADec 1, 1998
Controlling proliferation of cells before and after encapsulation in a bioartificial organ by gene transformation
CYTOTHERAPEUTICS INC9 citations74
NEUROTECH SA
10 patentsUS6436427B1Aug 20, 2002
Device and method for treating ophthalmic diseases
NEUROTECH SA137 citations97
US6299895B1Oct 9, 2001
Device and method for treating ophthalmic diseases
NEUROTECH SA231 citations97
US6649184B2Nov 18, 2003
Device and method for treating ophthalmic diseases
NEUROTECH SA39 citations95
US6392118B1May 21, 2002
Mx-1 conditionally immortalized cells
NEUROTECH SA39 citations94
US6264941B1Jul 24, 2001
Compositions for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules
NEUROTECH SA21 citations92
US6495364B2Dec 17, 2002
Mx-1 conditionally immortalized cells
NEUROTECH SA24 citations91
US6225448B1May 1, 2001
1gG /transferrin receptor fusion protein
NEUROTECH SA29 citations91
US6197294B1Mar 6, 2001
Cell surface molecule-induced macrophage activation
NEUROTECH SA21 citations91
US6506891B2Jan 14, 2003
Cell surface molecule-induced macrophage activation
NEUROTECH SA2 citations61
US7189837B2Mar 13, 2007
Cell surface molecule-induced macrophage activation
NEUROTECH SA0 citations51
NEUROSPHERES HOLDINGS LTD
7 patentsUS6497872B1Dec 24, 2002
Neural transplantation using proliferated multipotent neural stem cells and their progeny
NEUROSPHERES HOLDINGS LTD259 citations99
US6071889AJun 6, 2000
In vivo genetic modification of growth factor-responsive neural precursor cells
NEUROSPHERES HOLDINGS LTD168 citations99
US5750376AMay 12, 1998
In vitro growth and proliferation of genetically modified multipotent neural stem cells and their progeny
NEUROSPHERES HOLDINGS LTD648 citations99
US6294346B1Sep 25, 2001
Use of multipotent neural stem cells and their progeny for the screening of drugs and other biological agents
NEUROSPHERES HOLDINGS LTD115 citations98
US7101709B2Sep 5, 2006
Methods of screening biological agents
NEUROSPHERES HOLDINGS LTD37 citations96
US7115418B2Oct 3, 2006
Methods of proliferating undifferentiated neural cells
NEUROSPHERES HOLDINGS LTD27 citations92
US7166277B1Jan 23, 2007
Remyelination of neurons using multipotent neural stem cell progeny
NEUROSPHERES HOLDINGS LTD12 citations84